Trade

with

Advaxis Inc
(NASDAQ: ADXS)
AdChoices
2.85
-0.03
-1.04%
After Hours :
-
-
-

Open

2.86

Previous Close

2.88

Volume (Avg)

79.92k (249.33k)

Day's Range

2.82-2.93

52Wk Range

2.46-5.99

Market Cap.

55.63M

Dividend Rate ( Yield )

-

Beta

1.11

Shares Outstanding

19.52M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • -

    • Net Income

    • -

    • Market Cap.

    • 55.63M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -2,068.80

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.11

    • Forward P/E

    • -2.74

    • Price/Sales

    • 40.16

    • Price/Book Value

    • 2.39

    • Price/Cash flow

    • -2.41

      • EBITDA

      • -

      • Return on Capital %

      • -135.79

      • Return on Equity %

      • -250.07

      • Return on Assets %

      • -135.79

      • Book Value/Share

      • 1.19

      • Shares Outstanding

      • 19.52M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 15.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -1.05

        • Cashflow Estimate

        • -0.81

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -2,131.36

            • 39.38

            • Net Profit Margin

            • -2,068.80

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 8.31

              • 2.92

              • Quick Ratio

              • 7.91

              • 2.35

              • Interest Coverage

              • -53.23

              • 38.02

              • Leverage Ratio

              • 1.12

              • 2.21

              • Book Value/Share

              • 1.19

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.94

                • 196.08

                • P/E Ratio 5-Year High

                • -21.71

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.35

                • 124.82

                • Price/Sales Ratio

                • 40.16

                • 9.12

                • Price/Book Value

                • 2.39

                • 8.26

                • Price/Cash Flow Ratio

                • -2.41

                • 47.39

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -250.07

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -135.79

                    (-197.70)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -212.92

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.07

                  • 0.55

                  Current Historical
                  Ownership

                  Institutional Ownership

                  10.38%

                  Top 10 Institutions

                  9.47%

                  Mutual Fund Ownership

                  2.79%

                  Float

                  96.93%

                  5% / Insider Ownership

                  17.02%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    254,220

                  • 0.00

                  • 1.30

                  • Vanguard Extended Market Index Fund

                  •  

                    108,709

                  • 30.89

                  • 0.56

                  • Vanguard Instl Total Stock Market Index

                  •  

                    69,438

                  • 0.00

                  • 0.36

                  • SCS Tactical Allocation Fund

                  •  

                    66,160

                  • 0.00

                  • 0.34

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    40,574

                  • 0.00

                  • 0.21

                  • AXA/Lord Abbett Micro Cap Portfolio

                  •  

                    3,508

                  • 0.00

                  • 0.02

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    1,946

                  • 0.00

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Group, Inc.

                  •  

                    393,009

                  • +17.18%

                  • 2.04

                  • Jefferies & Company, Inc.

                  •  

                    351,634

                  • +278.63%

                  • 1.82

                  • Silverback Aset Management LLC

                  •  

                    308,210

                  • -22.95%

                  • 1.60

                  • Knoll Capital Management LP

                  •  

                    225,000

                  • 0.00%

                  • 1.17

                  • Susquehanna Financial Group, LLLP

                  •  

                    108,925

                  • +597.21%

                  • 0.56

                  • Sentinel Capital Solutions, Inc

                  •  

                    66,160

                  • 0.00%

                  • 0.34

                  • Davidson D A & Co

                  •  

                    56,000

                  • +33.33%

                  • 0.29

                  • Wells Fargo Bank NA

                  •  

                    47,058

                  • 0.00%

                  • 0.24

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Slow Growth

                  Style

                  Small Growth

                  Advaxis Inc is a clinical development stage biotechnology company. The company is engaged in developing safe & effective immunotherapies for cancer & infectious diseases.

                  Key People

                  Daniel J. O'Connor

                  CEO/President/Director

                  Dr. James Patton

                  Chairman of the Board/Director

                  Ms. Sara Bonstein

                  CFO

                  Mr. Gregory T. Mayes, III

                  COO/Executive VP

                  Mr. Robert Petit, PhD

                  Chief Scientific Officer/Executive VP

                  • Advaxis Inc

                  • 305 College Road East

                  • Princeton, NJ 08540

                  • USA.Map

                  • Phone: +1 609 452-9813

                  • Fax: +1 609 452-9818

                  • advaxis.com

                  Incorporated

                  1987

                  Employees

                  17

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: